可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Jorge-Herrero E, Fernandez P, Turnay J, et al. Influence of different chemical crosslinking treatments on the properties of bovine pericardium and collagen[J]. Biomaterials, 1999, 20(6):539-545.
[2] Nugent HM, Edelman ER. Tissue engineering therapy for cardiovascular disease[J]. Circ Res, 2003, 92(10):1068-1078.
[3] Chang Y, Hsu CK, Wei HJ, et al. Cell-free xenogenic vascular grafts fixed with glutaraldehyde or genipin: In vitro and in vivo studies[J]. J Biotechnol, 2005, 120(2):207-219.
[4] Moore MA, Adams AK. Calcification resistance, biostability and low immunogenic potential of porcine heart valves modified by dye-mediated photooxidation[J]. J Biomed Mater Res, 2001, 56(1):24-30.
[5] Moore MA, Bohachevsky IK, Cheung DT, et al. Stabilization of pericardial tissue by dye-mediated photooxidation[J]. J Biomed Mater Res, 1994, 28(5):611-618.
[6] Adams AK, Talman EA, Campbell L, et al. Crosslink formation in porcine valves stabilized by dye-mediated photooxidation[J]. J Biomed Mater Res, 2001, 57(4):582-587.
[7] Svendsen CA, Kreykes NS, Butany J, et al. In vivo assessment of a photofixed bovine pericardial valve[J]. J Heart Valve Dis, 2000, 9(6):813-820.
[8] Schmidt CE, Baier JM. Acellular vascular tissue: natural biomaterials for tissue engineering[J]. Biomaterials, 2000, 21(22):2215-2231.
[9] Breymann T, Thies WR, Boehtig DR. et al. Bovine valved xenografts for RVOT reconstruction: results after 71 implantations[J]. Eur J Cardiothorac Surg, 2002, 21(4):703-710.
[10]Fann JI, Miller DC, Moore KA, et al. Twenty-year clinical experience with porcine bioprosthesis[J]. Ann Thorac Surg, 1996, 62(5):1301-1311.